Recombinant human TNF-α receptor II IgG Fc fusion protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human TNF-α receptor II IgG Fc fusion protein, covering 2019-12-19 to 2019-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein [Phase 4]